| Dr Khaled M Krisht, | |
|
6020 Warden Rd Ste 100, Sherwood, AR 72120-6068 | |
| (501) 552-6400 | |
| (501) 552-6430 |
| Full Name | Dr Khaled M Krisht |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 16 Years |
| Location | 6020 Warden Rd Ste 100, Sherwood, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689822314 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 35367 (Alabama) | Secondary |
| 207T00000X | Neurological Surgery | E-9067 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Vincent Medical Center/north | Sherwood, AR | Hospital |
| Chi-st Vincent Infirmary | Little rock, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healing Arts Center L.l.c. | 4789620261 | 51 |
| St Vincent Medical Group | 5698758803 | 139 |
News Archive
The mutation occurs in the androgen-synthesizing enzyme 3βHSD1 in castration-resistant prostate cancer (CRPC), according to research published online today in Cell. This mutation enables the tumor to make its own supply of androgens, a hormone that fuels the growth of the prostate cancer.
Cytori Therapeutics announced today the publication of RESTORE-2 trial results in the peer-reviewed European Journal of Surgical Oncology.
According to a latest study supported by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, the deadly Zika virus could be used to kill a specific type of brain cancer cells and sparing the neighbouring healthy brain cells. Although experimental in stage, this finding has wide implications for those suffering from these cancers.
SunLink Health Systems, Inc. today announced earnings from continuing operations for its fiscal quarter ended September 30, 2009 of $549,000, or $0.07 per fully diluted share, compared to a loss from continuing operations of $603,000, or $0.08 per fully diluted share, for the quarter ended September 30, 2008. Included in the results for the fiscal quarter ended September 30, 2009 is the pre-tax gain of $2,342,000 from the September 2009 sale of three home health businesses.
› Verified 2 days ago
| Entity Name | St Vincent Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134176480 PECOS PAC ID: 5698758803 Enrollment ID: O20040622000224 |
News Archive
The mutation occurs in the androgen-synthesizing enzyme 3βHSD1 in castration-resistant prostate cancer (CRPC), according to research published online today in Cell. This mutation enables the tumor to make its own supply of androgens, a hormone that fuels the growth of the prostate cancer.
Cytori Therapeutics announced today the publication of RESTORE-2 trial results in the peer-reviewed European Journal of Surgical Oncology.
According to a latest study supported by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, the deadly Zika virus could be used to kill a specific type of brain cancer cells and sparing the neighbouring healthy brain cells. Although experimental in stage, this finding has wide implications for those suffering from these cancers.
SunLink Health Systems, Inc. today announced earnings from continuing operations for its fiscal quarter ended September 30, 2009 of $549,000, or $0.07 per fully diluted share, compared to a loss from continuing operations of $603,000, or $0.08 per fully diluted share, for the quarter ended September 30, 2008. Included in the results for the fiscal quarter ended September 30, 2009 is the pre-tax gain of $2,342,000 from the September 2009 sale of three home health businesses.
› Verified 2 days ago
| Entity Name | Surgical Associates Of Jonesboro, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184869943 PECOS PAC ID: 0749346658 Enrollment ID: O20090302000205 |
News Archive
The mutation occurs in the androgen-synthesizing enzyme 3βHSD1 in castration-resistant prostate cancer (CRPC), according to research published online today in Cell. This mutation enables the tumor to make its own supply of androgens, a hormone that fuels the growth of the prostate cancer.
Cytori Therapeutics announced today the publication of RESTORE-2 trial results in the peer-reviewed European Journal of Surgical Oncology.
According to a latest study supported by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, the deadly Zika virus could be used to kill a specific type of brain cancer cells and sparing the neighbouring healthy brain cells. Although experimental in stage, this finding has wide implications for those suffering from these cancers.
SunLink Health Systems, Inc. today announced earnings from continuing operations for its fiscal quarter ended September 30, 2009 of $549,000, or $0.07 per fully diluted share, compared to a loss from continuing operations of $603,000, or $0.08 per fully diluted share, for the quarter ended September 30, 2008. Included in the results for the fiscal quarter ended September 30, 2009 is the pre-tax gain of $2,342,000 from the September 2009 sale of three home health businesses.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Khaled M Krisht, 6020 Warden Rd Ste 100, Sherwood, AR 72120-6068 Ph: (501) 552-6400 | Dr Khaled M Krisht, 6020 Warden Rd Ste 100, Sherwood, AR 72120-6068 Ph: (501) 552-6400 |
News Archive
The mutation occurs in the androgen-synthesizing enzyme 3βHSD1 in castration-resistant prostate cancer (CRPC), according to research published online today in Cell. This mutation enables the tumor to make its own supply of androgens, a hormone that fuels the growth of the prostate cancer.
Cytori Therapeutics announced today the publication of RESTORE-2 trial results in the peer-reviewed European Journal of Surgical Oncology.
According to a latest study supported by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, the deadly Zika virus could be used to kill a specific type of brain cancer cells and sparing the neighbouring healthy brain cells. Although experimental in stage, this finding has wide implications for those suffering from these cancers.
SunLink Health Systems, Inc. today announced earnings from continuing operations for its fiscal quarter ended September 30, 2009 of $549,000, or $0.07 per fully diluted share, compared to a loss from continuing operations of $603,000, or $0.08 per fully diluted share, for the quarter ended September 30, 2008. Included in the results for the fiscal quarter ended September 30, 2009 is the pre-tax gain of $2,342,000 from the September 2009 sale of three home health businesses.
› Verified 2 days ago
Adedamola Adepoju, M.D Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6020 Warden Rd Ste 100, Sherwood, AR 72120 Phone: 501-552-6400 Fax: 501-552-6430 | |
Ali Krisht, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6020 Warden Rd Ste 100, Sherwood, AR 72120 Phone: 501-552-6400 Fax: 501-552-6448 | |
Jaafar Basma, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6020 Warden Rd Ste 100, Sherwood, AR 72120 Phone: 501-552-6400 Fax: 501-552-6430 | |
Dr. Paul Lee, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6020 Warden Rd, Suite 100, Sherwood, AR 72120 Phone: 501-552-6400 Fax: 501-552-6430 | |
Dr. Stylianos Kyriakos Rammos, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6020 Warden Rd Ste 100, Sherwood, AR 72120 Phone: 501-552-6400 Fax: 501-552-6430 | |
Tarek Abuelem, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6020 Warden Rd, Suite 100, Sherwood, AR 72120 Phone: 501-552-6400 Fax: 501-552-6430 |